• Regeneron Pharmaceuticals average return on equity for 2023 was 17.65, a 41.86% decline from 2022.
• Regeneron Pharmaceuticals average return on equity for 2022 was 30.36, a 36.45% decline from 2021.
• Regeneron Pharmaceuticals average return on equity for 2021 was 47.77, a 70.85% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.